Pradeep Chaluvally-Raghavan, PhD

Publications

• B Cells as an Immune-Regulatory Signature in Ovarian Cancer.

  (Gupta P, Chen C, Chaluvally-Raghavan P, Pradeep S.) Cancers (Basel). 2019 Jun 26;11(7).

• ERBB signaling in CTCs of ovarian cancer and glioblastoma.

  (Geethadevi A, Parashar D, Bishop E, Pradeep S, Chaluvally-Raghavan P.) Genes Cancer. 2017 Nov;8(11-12):746-751.

• miRNA-Mediated RNA Activation in Mammalian Cells.

  (Ramchandran R, Chaluvally-Raghavan P.) Adv Exp Med Biol. 2017;983:81-89.

• Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.

  (Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GB.) Cell Rep. 2016 05 17;15(7):1493-1504.

• Targeting ncRNAs in the 3q26.2 amplicon.

  (Chaluvally-Raghavan P, Mills GB.) Oncoscience. 2015;2(8):671-2.

• Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.

  (Chaluvally-Raghavan P, Zhang F, Pradeep S, Hamilton MP, Zhao X, Rupaimoole R, Moss T, Lu Y, Yu S, Pecot CV, Aure MR, Peuget S, Rodriguez-Aguayo C, Han HD, Zhang D, Venkatanarayan A, Krohn M, Kristensen VN, Gagea M, Ram P, Liu W, Lopez-Berestein G, Lorenzi PL, Børresen-Dale AL, Chin K, Gray J, Dusetti NJ, McGuire SE, Flores ER, Sood AK, Mills GB.) Cancer Cell. 2014 Dec 08;26(6):863-879.

• Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

  (Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, Pecot CV, Kim SJ, Choi HJ, Bischoff FZ, Mayer JA, Huang L, Nick AM, Hall CS, Rodriguez-Aguayo C, Zand B, Dalton HJ, Arumugam T, Lee HJ, Han HD, Cho MS, Rupaimoole R, Mangala LS, Sehgal V, Oh SC, Liu J, Lee JS, Coleman RL, Ram P, Lopez-Berestein G, Fidler IJ, Sood AK.) Cancer Cell. 2014 Jul 14;26(1):77-91.